Methotrexate and Basal cell carcinoma - from FDA reports


Summary

Basal cell carcinoma is found among people who take Methotrexate, especially for people who are female, 60+ old , have been taking the drug for 1 - 2 years, also take medication Folic Acid, and have Osteoporosis. This review analyzes which people have Basal cell carcinoma with Methotrexate. It is created by eHealthMe based on reports of 231,270 people who have side effects when taking Methotrexate from FDA , and is updated regularly.

What to expect?

If you take Methotrexate and have Basal cell carcinoma, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Methotrexate and have Basal cell carcinoma

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Aug, 22, 2017

231,270 people reported to have side effects when taking Methotrexate.
Among them, 1,171 people (0.51%) have Basal cell carcinoma


Number of reports submitted per year:

Could Methotrexate cause Basal cell carcinoma?

Time on Methotrexate when people have Basal cell carcinoma *:

  • < 1 month: 9.68 %
  • 1 - 6 months: 9.68 %
  • 6 - 12 months: 11.83 %
  • 1 - 2 years: 21.51 %
  • 2 - 5 years: 20.43 %
  • 5 - 10 years: 17.2 %
  • 10+ years: 9.68 %

Gender of people who have Basal cell carcinoma when taking Methotrexate *:

  • female: 66.4 %
  • male: 33.6 %

Age of people who have Basal cell carcinoma when taking Methotrexate *:

  • 0-1: 0.0 %
  • 2-9: 0.48 %
  • 10-19: 0.48 %
  • 20-29: 0.95 %
  • 30-39: 1.19 %
  • 40-49: 10.86 %
  • 50-59: 20.17 %
  • 60+: 65.75 %

Top conditions involved for these people *:

  • Psoriatic Arthropathy (67 people, 5.72%)
  • Osteoporosis (67 people, 5.72%)
  • High Blood Pressure (51 people, 4.36%)
  • Crohn's Disease (51 people, 4.36%)
  • High Blood Cholesterol (33 people, 2.82%)

Top co-used drugs for these people *:

  • Folic Acid (380 people, 32.45%)
  • Remicade (371 people, 31.68%)
  • Humira (188 people, 16.05%)
  • Prednisone (159 people, 13.58%)
  • Enbrel (149 people, 12.72%)

Top other side effects for these people *:

  • Rashes (92 people, 7.86%)
  • Pain (84 people, 7.17%)
  • Squamous Cell Carcinoma (80 people, 6.83%)
  • Drug Ineffective (72 people, 6.15%)
  • Osteoarthritis (63 people, 5.38%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Basal cell carcinoma when taking Methotrexate?

Expand the study to include all drugs with the same ingredients

Basal cell carcinoma and drugs with ingredients of methotrexate sodium.

Expand the study to include reports from both FDA and eHealthMe

Basal cell carcinoma and Methotrexate from FDA and eHealthMe reports

Methotrexate

Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. (latest outcomes from Methotrexate 234,877 users)

Basal cell carcinoma

Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills) has been reported by people with rheumatoid arthritis, osteoporosis, multiple sclerosis, high blood pressure, psoriasis (latest reports from 10,683 Basal cell carcinoma patients).

Browse all side effects of Methotrexate

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Basal cell carcinoma

Basal cell carcinoma

Could your condition cause Basal cell carcinoma

Basal cell carcinoma

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Methotrexate and have Basal cell carcinoma.

Questions to the study

More questions >

User reviews to the study

More reviews >